🇺🇸 United States FDA

Tirzepatide

Dual GLP-1/GIP receptor agonist approved for diabetes and obesity

Approved prescription FDA
Key stats Research
~22%
Body weight reduction (SURMOUNT-1, 72wk)
Dual
GIP/GLP-1 receptor agonist
Approved
Mounjaro & Zepbound approved
Eli Lilly
Developer
🇺🇸 United States FDA

🇺🇸 United States · FDA

Legal status

🇺🇸 United States — FDA
℞ Prescription required

Tirzepatide is an approved prescription medicine in most markets. Requires a prescription for therapeutic use. Verify current status before ordering.

This website is intended for research and educational purposes only. The information provided does not constitute medical advice and should not be used to diagnose, treat, cure, or prevent any condition. Peptides discussed on this site are not approved by the FDA for human therapeutic use. Always consult a qualified healthcare professional before using any substance.

Full legal guide for United States →

Frequently asked

Common questions

Is Tirzepatide legal in United States?

Tirzepatide is an approved prescription medicine in United States. It requires a prescription for legal therapeutic use and is available from pharmacies and prescribing clinicians.

Can I buy Tirzepatide in United States?

Tirzepatide is available from pharmacies in United States with a valid prescription.

Where to source Tirzepatide

Tirzepatide in United States

We verify COA documentation and purity standards before listing any vendor.

Get vendor access →